The efficacy of saline washout technique in the management of exfoliant and vesicant chemotherapy extravasation: a historical case series report

Abstract

N. (2013). The efficacy of saline washout technique in the management of exfoliant and vesicant chemotherapy extravasation: a historical case series report. European Journal Of Cancer Care, 22(2), pp. 169-178. doi: 10.1111/ecc.12023 This is the unspecified version of the paper.This version of the publication may differ from the final published version. This report presents the results from an historical case series of cytotoxic drug extravasations managed by saline washout; its purpose is to assess the efficacy of the procedure based on patient outcome. 89 patients were identified as having experienced a vesicant or exfoliant extravasation from incident reports filed over a 10 year period, from 1 st April 2001 -31 st March 2011. Outcome was measured against the need for further surgical treatment being required. Of the 89 cases assessed for efficacy of saline washout one patient experienced a wound infection which was treated effectively with oral antibiotics. There were no other complications reported and no patients required further treatment with surgical debridement. The majority of patients had no deferral of treatment as chemotherapy could be continued in their unaffected arm immediately following saline washout procedure. For patients where cannulation in their opposite arm for continuation of treatment was not advisable chemotherapy was delayed between 3 to 7 days. Hospitalisation as a result of the extravasation or subsequent treatment was not required in any of the 89 cases. Results indicate that saline washout technique is a safe and effective management strategy for the treatment of both vesicant and exfoliant chemotherapy extravasation. Permanent

Port-a-Cath® extravasation of vesicant cytotoxics: Surgical options for a rare complication of cancer chemotherapy

“…Since then, several authors have demonstrated the efficacy of this procedure in the peripheral situation. 21 However, for central venous catheters, the utility of this approach has not been described. Moreover, it is entirely unclear how much of the extravasated agent can be retrieved by the SWOP when it is applied to the affected area, and by wound drainage after surgery.…”

Managing chemotherapy extravasation in totally implantable central venous access: Use of subcutaneous wash-out technique

“…[16][17][18] This risk of cytotoxic drug extravasations may be also increased by the multiplicity of chemotherapy treatments that patients can receive over a number of years. 19 However, there is a need to be able to assure the highest quality and efficiency of care, while also controlling the impact of treatments on patient outcome. Despite this, chemotherapy extravasation management remains controversial, and there is no definitive standard procedure to solve the problem.…”

Treating extravasation injuries in infants and young children: a scoping review and survey of UK NHS practice

“…Consequently, it is unsurprising that policies seem to be largely based on historical practice within hospitals or expert opinion, rather than on published guidelines. [10] This study aimed to begin the process of resolving the uncertainty surrounding which treatments may be best for treating extravasation injuries in infants and young children. This was done by undertaking both a systematic scoping review and an NHS survey of current practice and opinions.…”